Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of sublingual fentanyl orally disintegrating tablets in patients with breakthrough pain: multicentre prospective study.
Guitart J, Vargas I, De Sanctis V, Ferreras J, Fuentes J, Salazar R, Vázquez JM, Folch J, Moya J, Ribera H, Rodelas F, Tomás A, Arilla M, Coma J, Aberasturi T, Sintes D, Lombán E. Guitart J, et al. Among authors: de sanctis v. Clin Drug Investig. 2013 Sep;33(9):675-83. doi: 10.1007/s40261-013-0111-z. Clin Drug Investig. 2013. PMID: 23881567 Clinical Trial.
Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Guitart J, et al. Among authors: de sanctis v. Drugs R D. 2017 Sep;17(3):419-425. doi: 10.1007/s40268-017-0198-4. Drugs R D. 2017. PMID: 28744772 Free PMC article.
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Guitart J, et al. Among authors: de sanctis v. Drugs R D. 2018 Jun;18(2):119-128. doi: 10.1007/s40268-018-0231-2. Drugs R D. 2018. PMID: 29572732 Free PMC article.
Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Guitart J, et al. Among authors: de sanctis v. Drugs R D. 2018 Sep;18(3):247-248. doi: 10.1007/s40268-018-0239-7. Drugs R D. 2018. PMID: 29987670 Free PMC article.
Erratum to: Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ. Guitart J, et al. Among authors: de sanctis v. Clin Drug Investig. 2016 Aug;36(8):695. doi: 10.1007/s40261-016-0416-9. Clin Drug Investig. 2016. PMID: 27256618 No abstract available.
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, Draghini L, Fodor A, D'Agostino GR, Russo D, Balcet V, Ferioli M, Vicenzi L, Raguso A, Di Cataldo V, Perrucci E, Borghesi S, Ippolito E, Gentile P, De Sanctis V, Titone F, Delle Curti CT, Huscher A, Gambacorta MA, Ferrandina G, Morganti AG, Deodato F. Macchia G, et al. Among authors: de sanctis v. Gynecol Oncol. 2024 May;184:16-23. doi: 10.1016/j.ygyno.2024.01.023. Epub 2024 Jan 24. Gynecol Oncol. 2024. PMID: 38271773
606 results